By analyzing relevant genes in the TCGA and Chinese Glioma Genome Atlas, we found that the expression of G6PD and H6PD, the two genes encoding glucose-6 phosphate dehydrogenase, was increased in glioma patients, particularly H6PD. This evidence concerns the gene H6PD and central nervous system cancer.